文献速递主动脉疾病

胸主动脉腔内修复术后植入后综合征的危险因素与围手术期结局

Risk Factors and Perioperative Outcomes of Postimplantation Syndrome After Thoracic Endovascular Aortic Repair.
PubMed 文献 · J Endovasc Ther · 2025-03-25

这项回顾性、观察性、单中心队列纳入2010年2月至2022年11月间369例连续胸主动脉腔内修复(TEVAR)手术,旨在明确植入后综合征(PIS)的发生率与危险因素。PIS发生率为26.8%,胸主动脉覆盖长度>150 mm、冠心病和术前白细胞计数为危险因素,既往主动脉手术为保护因素;PIS与住院时间延长相关。

要点

  • TEVAR术后PIS发生率为26.8%(369例连续手术队列)。
  • 胸主动脉覆盖>150 mm(OR 4.7)、冠心病(OR 2.1)、术前白细胞计数(OR 1.1)为PIS危险因素。
  • 既往主动脉手术(OR 0.5)为PIS保护因素,PIS患者住院时间中位16.0天 vs 非PIS患者8.0天。

核心结论

  • 本队列中PIS发生率为26.8%。
  • 胸主动脉覆盖长度、冠心病和术前白细胞计数被确定为TEVAR术后PIS的危险因素,而既往主动脉手术为保护因素。
  • PIS似乎对住院时间有显著影响。

研究设计与样本

  • 回顾性、观察性、单中心队列研究,纳入2010年2月至2022年11月间369例连续TEVAR手术。
  • 纳入近端锚定区位于0至5区的患者。
  • 收集合并症、既往主动脉手术与形态、胸主动脉覆盖、支架移植物组成、术中变量及术后结局数据。
  • 术前及TEVAR后48小时记录白细胞(WBC)和C反应蛋白(CRP)血清水平。
  • PIS定义为同时存在发热(鼓膜温度≥38.0°C)、CRP血清水平>0.7 mg/dl及术后胸部X线片显示胸腔积液。

主要发现

  • PIS患者高脂血症比例高于非PIS患者(56.6% vs 44.8%,p=0.045)。
  • 支架移植物组成在引发PIS方面未起重要作用。
  • PIS是延长住院时间的统计学显著因素(PIS患者中位16.0天 vs 非PIS患者8.0天,p<0.001)。
  • 胸主动脉覆盖>150 mm(OR 4.7,p=0.004)、冠心病(OR 2.1,p=0.028)和术前WBC计数(OR 1.1,p=0.047)为PIS危险因素。
  • 既往主动脉手术(OR 0.5,p=0.05)为保护因素;胸主动脉覆盖是WBC和CRP水平升高的显著危险因素(p<0.001)。

临床怎么用

  • 作者指出,鉴于当前和既往研究识别的危险因素,需要进一步研究以确定降低PIS发生率的策略。
  • 作者指出,有必要评估在接受TEVAR的患者中术前预防性治疗PIS的潜在实施。

局限性

  • 原文未报告局限性。
  • 作者在结论中提出需要进一步研究以确定降低PIS发生率的策略,并有必要评估术前预防性治疗的潜在实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Postimplantation syndrome (PIS) is a systemic inflammatory response that occurs following abdominal endovascular aortic repair (EVAR) and thoracic EVAR (TEVAR). The main outcome was to individuate the incidence and risk factors of PIS after TEVAR. Its impact on the length of stay and clinical outcomes were secondary objectives. MATERIALS AND METHODS: Three hundred sixty-nine consecutive TEVAR procedures performed between February 2010 and November 2022 were included in this retrospective cohort, observational, single-center study. Patients with proximal landing in zones 0 to 5 were enrolled. Data on comorbidities, previous aortic surgery and morphology, thoracic aorta coverage, stent-graft composition, intraoperative variables, and postoperative outcomes were collected. White blood cell (WBC) and C-reactive protein (CRP) serum levels were recorded preoperatively and 48 hours after TEVAR. PIS was defined as the concomitant presence of fever (tympanic temperature ≥38.0°C), CRP serum level >0.7 mg/dl and evidence of pleural effusion on postoperative chest radiograph. RESULTS: PIS incidence in our cohort was 26.8%. PIS patients presented with a higher rate of hyperlipidemia (56.6% vs 44.8%, p = 0.045) than non-PIS patients. Stent-graft composition did not play a relevant role in eliciting PIS. PIS was a statistically significant factor in prolonging patients' stay (median 16.0 days vs 8.0 days, p < 0.001, PIS and non-PIS patients). Thoracic aortic coverage >150 mm (Odds Ratio (OR) 4.7, p = 0.004), coronary artery disease (OR 2.1, p = 0.028), and preoperative WBC count (OR 1.1, p = 0.047) were identified as risk factors for PIS, whereas previous aortic surgery (OR 0.5, p = 0.05) was highlighted as a protective factor. Thoracic aortic coverage was a significant risk factor for increased WBC and CRP levels (p < 0.001). CONCLUSION: PIS incidence was 26.8% in our cohort. Thoracic aortic coverage, coronary artery disease, and preoperative WBC count were identified as risk factors for PIS after TEVAR, whereas previous aortic surgery was found to be a protective factor. PIS also appeared to have a significant impact on length of stay.Clinical ImpactThis study identified a significant occurrence of post-implantation syndrome (PIS) following TEVAR, affecting over 25% of patients and adversely affecting the duration of hospital stay. Stent graft material did not seem to influence the incidence of PIS. Thoracic aortic coverage, coronary artery disease, and preoperative white blood cell (WBC) count have been identified as risk factors, whereas previous aortic surgery has been found to serve as a protective factor, representing a novel finding in the literature. Further research is warranted to ascertain strategies for mitigating the incidence of PIS, considering the risk factors identified in both current and prior studies. In addition, it is necessary to evaluate the potential implementation of preoperative prophylactic therapy for PIS in patients undergoing TEVAR.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Leone N, Bartolotti LAM, Migliari M, et al. Risk Factors and Perioperative Outcomes of Postimplantation Syndrome After Thoracic Endovascular Aortic Repair. J Endovasc Ther. 2025. PMID: 40129282. doi:10.1177/15266028251325764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。